We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
-7.31%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.76B
AUM Growth
+$118M
(+7.2%)
Cap. Flow
+$242M
Cap. Flow
% of AUM
13.74%
Top 10 Holdings %
Top 10 Hldgs %
58.08%
Holding
55
New
13
Increased
19
Reduced
5
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$94.3M |
| 2 |
Quest Diagnostics
DGX
|
+$88.9M |
| 3 |
DexCom
DXCM
|
+$68.5M |
| 4 |
Edwards Lifesciences
EW
|
+$60.4M |
| 5 |
Zimmer Biomet
ZBH
|
+$59.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$112M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$105M |
| 3 |
BCR
CR Bard Inc.
BCR
|
+$83M |
| 4 |
Abbott
ABT
|
+$74.5M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$59.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.19% |
| 2 | Financials | 3.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Vertex Pharmaceuticals
VRTX
$119B
| – | – |
-471,970
| Closed | -$59.4M |
|
52
Viatris
VTRS
$20.5B
| – | – |
-901,510
| Closed | -$48.7M |
|
|
KND
53
DELISTED
Kindred Healthcare
KND
| – | – |
-1,400,000
| Closed | -$16.7M |
|
|
SGNT
54
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| – | – |
-1,750,000
| Closed | -$27.8M |
|
|
BXLT
55
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| – | – |
-2,690,440
| Closed | -$105M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q1 2016 Portfolio in Review
As of Q1 2016, HealthCor Management held 55 positions worth $1.76B, up 7.2% from $1.65B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
HealthCor Management deployed $242M of net new capital in Q1 2016, opening 13 new positions and adding to 19 existing holdings. Its largest new stake was Aetna Inc: 500,000 shares worth $56.2M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 72% a quarter earlier, followed by Financials.
On the sell side, the largest reduction was CR Bard Inc., an estimated $83M trimmed.
- HealthCor Management's largest Q1 2016 buy was Aetna Inc: 500,000 shares worth $56.2M.
- HealthCor Management added most to MALLINCKRODT PUBLIC LIMITED COMPANY in Q1 2016, an estimated $94.3M increase.
- HealthCor Management's biggest Q1 2016 reduction was CR Bard Inc., cutting an estimated $83M.
- HealthCor Management fully exited Eli Lilly in Q1 2016, selling an estimated $112M.
- HealthCor Management's ten largest holdings make up 58% of its $1.76B portfolio in Q1 2016.
- HealthCor Management opened 13 new positions and closed 17 in Q1 2016.
- HealthCor Management's portfolio value rose 7.2% quarter-over-quarter to $1.76B.
Based on HealthCor Management's 13F filing for Q1 2016, filed 16 May 2016.